Summary & Overview
CPT 93641: ICD Lead and Pulse Generator Testing
CPT code 93641 covers testing of implanted single- or dual-chamber implantable cardioverter-defibrillator (ICD) leads and the device pulse generator at the time of initial implantation or replacement. Nationally, this code reflects a critical peri-procedural service that ensures device integrity and patient safety by confirming lead function, sensing, pacing, and the generator’s power systems during implantation events. Appropriate coding and documentation for 93641 affect facility and professional claims during device implantation episodes and influence national utilization patterns for cardiac device procedures.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides comparative benchmarks and coding guidance context, focusing on how payers cover and reimburse device testing services tied to ICD implantation and replacement. Readers will find: payer coverage and reimbursement benchmarks; clinical context explaining when 93641 is reported (initial implant or replacement); and practical billing considerations including common modifiers and claim components. Data not available in the input for specific payer rates, associated taxonomies, and ICD-10 diagnoses are noted where relevant. The material is intended for billing managers, proceduralists, and policy analysts seeking a concise national overview of CPT code 93641 in the context of cardiac device implantation services.
Billing Code Overview
CPT code 93641 describes intraoperative or peri-implant testing of a single- or dual-chamber implantable cardioverter-defibrillator (ICD) system. The procedure evaluates the electrical performance of the device leads implanted in the heart and the device’s ability to detect and terminate abnormal ventricular rhythms. The clinician also tests the pulse generator, including the power source and controller, at the time of initial implantation or device replacement.
-
Service type: Device testing and interrogation performed in conjunction with ICD implantation or replacement
-
Typical site of service: Hospital operating room, cardiac catheterization lab, or inpatient procedural suite
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with ischemic cardiomyopathy undergoes implantation of a single- or dual-chamber implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death. The interventional electrophysiologist implants transvenous leads in the right atrium and/or right ventricle and connects them to a pulse generator. At the time of initial implant or when replacing the pulse generator, intraoperative device interrogation and lead testing are performed to confirm adequate sensing, pacing thresholds, lead impedances, and defibrillation system integrity. The clinical workflow includes pre-procedure device programming review, sterile device pocket creation, lead placement under fluoroscopic guidance, intraoperative testing of pacing and sensing at multiple outputs and rates, defibrillation threshold testing when indicated, verification of telemetry communication with the programmer, and final programming of detection and therapy parameters. Post-procedure documentation records lead measurements, pacing thresholds, sensing amplitudes, impedances, battery status, and any intraoperative complications; the procedure is typically billed as a device testing service at the time of implantation or replacement using 93641.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard billing | Use for routine reporting when no special circumstances apply |
| | Professional component | Use when reporting only the physician’s interpretation/component separate from technical services |